Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population

[1]  E. Ravussin,et al.  Metabolic Changes Following a 1-Year Diet and Exercise Intervention in Patients With Type 2 Diabetes , 2009, Diabetes.

[2]  M. Laakso,et al.  Gender Differences Relating to Metabolic Syndrome and Proinflammation in Finnish Subjects with Elevated Blood Pressure , 2009, Mediators of inflammation.

[3]  R. Hegele,et al.  Genetics of metabolic syndrome , 2008, Current diabetes reports.

[4]  Long‐Teng Lee,et al.  Betel nut chewing is associated with increased risk of cardiovascular disease and all-cause mortality in Taiwanese men. , 2008, The American journal of clinical nutrition.

[5]  Ming-Tsang Wu,et al.  Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. , 2008, Metabolism: clinical and experimental.

[6]  Chia-Ing Li,et al.  In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study) , 2007, Annals of the rheumatic diseases.

[7]  C-C Lin,et al.  Microalbuminuria and the metabolic syndrome and its components in the Chinese population , 2007, European journal of clinical investigation.

[8]  Ming-Tsang Wu,et al.  The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. , 2007, Metabolism: clinical and experimental.

[9]  C. Shih,et al.  Association Between Betelnut Chewing and Chronic Kidney Disease in Adults , 2007, Journal of occupational and environmental medicine.

[10]  O. Franco,et al.  Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. , 2007, Journal of the American College of Cardiology.

[11]  N. Forouhi,et al.  Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study , 2007, Diabetes.

[12]  M. Criqui,et al.  Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. , 2006, American heart journal.

[13]  G. Chertow,et al.  The metabolic syndrome and chronic kidney disease , 2006, Current opinion in nephrology and hypertension.

[14]  J. Guh,et al.  Betel-quid use is associated with the risk of the metabolic syndrome in adults. , 2006, The American journal of clinical nutrition.

[15]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[16]  K. Chien,et al.  Association of C-reactive Protein, Smoking and Metabolic Syndrome Among the Health Check-up Population , 2005 .

[17]  F. Rubiano,et al.  New bioimpedance analysis system: improved phenotyping with whole-body analysis , 2004, European Journal of Clinical Nutrition.

[18]  T. Chen,et al.  A population-based study of the association between areca nut chewing and Type 2 diabetes mellitus in men (Keelung Community-based Integrated Screening programme No. 2) , 2004, Diabetologia.

[19]  L. Niskanen,et al.  C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men , 2004, Diabetologia.

[20]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[21]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[22]  C. Agardh,et al.  Socio‐demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study , 2003, Diabetes, obesity & metabolism.

[23]  N. Cook,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.

[24]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  Diane Catellier,et al.  C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. , 2002, American heart journal.

[26]  A. Yamashina,et al.  Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[27]  N. Sattar,et al.  C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.

[28]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[29]  Paul M. Ridker,et al.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. , 2001, The New England journal of medicine.

[30]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[31]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[32]  Peter Søgaard,et al.  Electromechanical Mapping for Detection of Myocardial Viability in Patients With Ischemic Cardiomyopathy , 2001, Circulation.

[33]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[34]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[35]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[36]  P. Ridker,et al.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.

[37]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[38]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[39]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[40]  D L Sackett,et al.  Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. , 1996, Circulation.

[41]  L. Kuller,et al.  Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.

[42]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[43]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[44]  K. Jameson,et al.  An outpatient-based clinical program for type 2 diabetes prevention. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[45]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[46]  S. Maggi,et al.  The metabolic syndrome: The metabolic syndrome: a historical context , 2006 .

[47]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[48]  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.

[49]  G. E. Smith.  Medical Research. , 1920, Nature.